Go offline with the Player FM app!
New AACE Guidelines for Non-Alcoholic Fatty Liver Disease - Frankly Speaking Ep 302
Manage episode 346924196 series 2738102
Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302
Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.
Episode resource links:
- AACE Guideline: Endocrine Pract: May 2022, 28(5): 528-562
- Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596
Guest: Robert A. Baldor, MD
Music Credit: Richard Onorato
504 episodes
Manage episode 346924196 series 2738102
Credits: 0.25 AMA PRA Category 1 Credit™
CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-302
Overview: Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the United States, with a prevalence rate of more than 30% of US adults. Most have not been diagnosed or treated. Join us to discuss the new AACE guidance on the diagnosis and treatment of NAFLD to reduce the burden of this common disease.
Episode resource links:
- AACE Guideline: Endocrine Pract: May 2022, 28(5): 528-562
- Coffee: Front Pharmacol. 2021 Dec 13;12:786596. doi: 10.3389/fphar.2021.786596
Guest: Robert A. Baldor, MD
Music Credit: Richard Onorato
504 episodes
Alle episoder
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.